Oxford University to test potential COVID-19 ‘wonder drug’ Ivermectin

LONDON: Oxford University researchers are planning to trial a drug that has shown signs of reducing COVID-19 deaths in developing countries.

The Principle trial is aiming to find a drug that works soon after virus symptoms appear in a patient, and one that is most effective during the primary stages of the illness, The Times reported.